Med. praxi. 2012;9(1):20-24
Overactive bladder (OAB) is characterized by episodes of urgency, micturition frequency, nycturia and, in majority of patients by urge
incontinence. It occurs frequently in older people and the prevalence increases with advancing age. 11–16 % of adult population is affected
and up to 20–30 % of elderly persons above 70 years. The treatment of choice are antimuscarininc drugs which supress detrusor
contraction by mechanism of blocking M3 and M2 muscarinic receptors in the bladder. Although there are fewer studies in geriatric
population all consistently prove antimuscarinics superiority over placebo. In primary care trospium chlorid was released for non-regulated
primary care physician prescribing. The risk of potential central anticholinergic adverse events is very low because trospium chlorid
does not cross blood-brain barrier. It is suitable also for older OAB patients with complex pharmacological regimen as it has a low risk
of drug interactions. Scientific evidence is sufficient for behavioral therapy in OAB. However, its implementation may be limited due to
availability or ability of the older patient to cooperate. In case the OAB treatment started by primary care physician is not sufficiently
effective the patient should be referred to a specialist´s treatment.
Published: February 13, 2012 Show citation